Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guerin

被引:3
作者
Meeks, Joshua J. [1 ]
Sexton, Wade J. [2 ]
Clark, Peter E. [3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[3] Levine Canc Inst, Atrium Hlth, Charlotte, NC USA
关键词
D O I
10.1097/JU.0000000000002779
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:526 / 527
页数:2
相关论文
共 7 条
[1]   Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events [J].
Brahmer, Julie R. ;
Abu-Sbeih, Hamzah ;
Ascierto, Paolo Antonio ;
Brufsky, Jill ;
Cappelli, Laura C. ;
Cortazar, Frank B. ;
Gerber, David E. ;
Hamad, Lamya ;
Hansen, Eric ;
Johnson, Douglas B. ;
Lacouture, Mario E. ;
Masters, Gregory A. ;
Naidoo, Jarushka ;
Nanni, Michele ;
Perales, Miguel-Angel ;
Puzanov, Igor ;
Santomasso, Bianca D. ;
Shanbhag, Satish P. ;
Sharma, Rajeev ;
Skondra, Dimitra ;
Sosman, Jeffrey A. ;
Turner, Michelle ;
Ernstoff, Marc S. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
[2]   Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline [J].
Chang, Sam S. ;
Boorjian, Stephen A. ;
Chou, Roger ;
Clark, Peter E. ;
Daneshmand, Siamak ;
Konety, Badrinath R. ;
Pruthi, Raj ;
Quale, Diane Z. ;
Ritch, Chad R. ;
Seigne, John D. ;
Skinner, Eila Curlee ;
Smith, Norm D. ;
McKiernan, James M. .
JOURNAL OF UROLOGY, 2016, 196 (04) :1021-1029
[3]  
Lerner SP, 2021, FDA Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC)
[4]   100 years of Bacillus Calmette-Guerin immunotherapy: from cattle to COVID-19 [J].
Lobo, Niyati ;
Brooks, Nathan A. ;
Zlotta, Alexandre R. ;
Cirillo, Jeffrey D. ;
Boorjian, Stephen ;
Black, Peter C. ;
Meeks, Joshua J. ;
Bivalacqua, Trinity J. ;
Gontero, Paolo ;
Steinberg, Gary D. ;
McConkey, David ;
Babjuk, Marko ;
Witjes, J. Alfred ;
Kamat, Ashish M. .
NATURE REVIEWS UROLOGY, 2021, 18 (10) :611-622
[5]  
Matulay JT, 2021, J UROLOGY, V205, P1612, DOI 10.1097/JU.0000000000001633
[6]   Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guerin-Naive High-Risk Nonmuscle-Invasive Bladder Cancer [J].
McElree, Ian M. ;
Steinberg, Ryan L. ;
Martin, Alex C. ;
Richards, Jordan ;
Mott, Sarah L. ;
Gellhaus, Paul T. ;
Nepple, Kenneth G. ;
O'Donnell, Michael A. ;
Packiam, Vignesh T. .
JOURNAL OF UROLOGY, 2022, 208 (03) :589-597
[7]   Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naive High-grade Non-muscle-invasive Bladder Cancer [J].
Svatek, Robert S. ;
Tangen, Cathy ;
Delacroix, Scott ;
Lowrance, William ;
Lerner, Seth P. .
EUROPEAN UROLOGY FOCUS, 2018, 4 (04) :522-524